Potential biomarkers for hepatoblastoma: Results from the SIOPEL-3 study

European Journal of Cancer

Volumn 48, Issue 12, 2012, Pages 1853-1859

  Purcell, Rachel ^a   Childs, Margaret ^b   Maibach, Rudolf ^c   Miles, Carina ^d   Turner, Clinton ^d   Zimmermann, Arthur ^e   Czauderna, Piotra ^f   Sullivan, Michael ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c SIAK Co ordinating Center   (Switzerland)

^d CANTERBURY HEALTH LABORATORIES   (New Zealand)

^e UNIVERSITY OF BERN   (Switzerland)

^f MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Catenin; AFP; Biomarker; Cyclin D1; E Cadherin; Hepatoblastoma; Ki 67; Liver tumour; SIOPEL

Indexed keywords

ALPHA FETOPROTEIN; BETA CATENIN; BIOLOGICAL MARKER; CYCLIN D1; KI 67 ANTIGEN; UVOMORULIN;

ARTICLE; CORRELATION ANALYSIS; HEPATOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT DISEASE; TISSUE MICROARRAY;

ALPHA-FETOPROTEINS; BETA CATENIN; CADHERINS; CYCLIN D1; HEPATOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LIVER NEOPLASMS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84864148581     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.10.019     Document Type: Article

References (33)

1. G. Perilongo, E. Shafford, and J. Plaschkes Liver Tumour Study Group of the International Society of Paediatric O. SIOPEL trials using preoperative chemotherapy in hepatoblastoma Lancet Oncol 1 2000 94 100 [Review] [28 Refs]
2. C.A. Stiller, J. Pritchard, and E. Steliarova-Foucher Liver cancer in European children: incidence and survival, 1978-1997. Report from the Automated Childhood Cancer Information System project Eur J Cancer 42 13 2006 2115 2123
3. R. Weksberg, C. Shuman, and J.B. Beckwith Beckwith-Wiedemann syndrome Eur J Hum Genet 18 1 2009 8 14
4. B.A. Hirschman, B.H. Pollock, and G.E. Tomlinson The spectrum of APC mutations in children with hepatoblastoma from familial adenomatous polyposis kindreds J Pediatr 147 2 2005 263 266
5. A. Zimmermann The emerging family of hepatoblastoma tumours: from ontogenesis to oncogenesis Eur J Cancer 41 11 2005 1503 1514
6. A. Zimmermann Pediatric liver tumors and hepatic ontogenesis: common and distinctive pathways Med Pediatr Oncol 39 5 2002 492 503
7. H. Blaker, W.J. Hofmann, and R.J. Rieker Beta-catenin accumulation and mutation of the CTNNB1 gene in hepatoblastoma Genes Chromosomes Cancer 25 4 1999 399 402
8. D.C. Brown, and K.C. Gatter Ki67 protein: the immaculate deception? Histopathology 40 1 2002 2 11
9. M. De Ioris, L. Brugieres, and A. Zimmermann Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience Eur J Cancer 44 4 2008 545 550
10. H. Yamaoka, K. Ohtsu, T. Sueda, T. Yokoyama, and E. Hiyama Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors Oncol Rep 15 3 2006 551 556
11. B. Zhai, H.X. Yan, and S.Q. Liu Reduced expression of E-cadherin/catenin complex in hepatocellular carcinomas World J Gastroenterol 14 37 2008 5665 5673
12. S.P. Monga Role of Wnt/beta-catenin signaling in liver metabolism and cancer Int J Biochem Cell Biol 43 7 2011 1021 1029
13. M. Peifer, and P. Polakis Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus Science 287 5458 2000 1606 1609
14. W.S. Park, R.R. Oh, and J.Y. Park Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma J Pathol 193 4 2001 483 490
15. R. Kemler From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion Trends Genet 9 9 1993 317 321
16. Y. Wu, and B.P. Zhou New insights of epithelial-mesenchymal transition in cancer metastasis Acta Biochim Biophys Sin 40 7 2008 643 650
17. R.A. Weinberg Mechanisms of malignant progression Carcinogenesis 29 6 2008 1092 1095
18. H. Semb, and G. Christofori The tumor-suppressor function of E-cadherin Am J Hum Genet 63 6 1998 1588 1593
19. G. Christofori, and H. Semb The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene Trends Biochem Sci 24 2 1999 73 76
20. J.P. Alao The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention Mol Cancer 6 2007 24
21. D.J. Liao, A. Thakur, J. Wu, H. Biliran, and F.H. Sarkar Perspectives on c-Myc, Cyclin D1, and their interaction in cancer formation, progression, and response to chemotherapy Crit Rev Oncog 13 2 2007 93 158
22. R. Stuart-Harris, C. Caldas, S.E. Pinder, and P. Pharoah Proliferation markers and survival in early breast cancer: a systematic review and meta-analysis of 85 studies in 32, 825 patients Breast 17 4 2008 323 334
23. M. Roach 3rd, F. Waldman, and A. Pollack Predictive models in external beam radiotherapy for clinically localized prostate cancer Cancer 115 13 Suppl. 2009 3112 3120
24. D. von Schweinitz, H. Hecker, G. Schmidt-von-Arndt, and D. Harms Prognostic factors and staging systems in childhood hepatoblastoma Int J Cancer 74 6 1997 593 599
25. G. Perilongo, R. Maibach, and E. Shafford Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma N Engl J Med 361 17 2009 1662 1670
26. J. Zsiros, R. Maibach, and E. Shafford Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study J Clin Oncol 28 15 2010 2584 2590
27. T. Ara, M. Fukuzawa, and T. Oue Immunohistochemical assessment of the MIB-1 Labeling Index in human hepatoblastoma and its prognostic relevance J Pediatr Surg 32 12 1997 1690 1694
28. J.M. Schnater, S.E. Kohler, W.H. Lamers, D. von Schweinitz, and D.C. Aronson Where do we stand with hepatoblastoma? A review Cancer 98 4 2003 668 678
29. R.L. Meyers, J.R. Rowland, and M. Krailo Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children's Oncology Group Pediatr Blood Cancer 53 6 2009 1016 1022
30. A. Ihara, H. Koizumi, R. Hashizume, and T. Uchikoshi Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas Hepatology 23 6 1996 1441 1447
31. P. Laurent-Puig, P. Legoix, and O. Bluteau Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis Gastroenterology 120 7 2001 1763 1773
32. Y.M. Jeng, M.Z. Wu, T.L. Mao, M.H. Chang, and H.C. Hsu Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma Cancer Lett 152 1 2000 45 51
33. Y. Wei, M. Fabre, and S. Branchereau Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas Oncogene 19 4 2000 498 504